Meningitis in diabetic patients.

Muli J, Seckova S, Sladeckova V, Steno J, Adamcova J, Rabarova L, Takacova M, Polonova J, Dudasova T, Pauerova K, Namulanda V, Okoth V, Juma O, Diana E, Johnson M, Deadline J, Bartkovjak M, Kolenova A, Taziarova M, Benca J, Njambi Z.
  Vol. 28 (Suppl 3) 2007 Neuro endocrinology letters Journal Article   2007; 28(Suppl 3): 28-29 PubMed PMID:  18030274    Citation  Keywords:  Anti-Bacterial Agents:therapeutic use, Cefotaxime:therapeutic use, Cohort Studies, Community-Acquired Infections:microbiology, Diabetes Complications:immunology, Diabetes Mellitus:immunology, Humans, Meningitis, Bacterial:etiology, Outcome Assessment (Hea.   

: Community acquired bacterial (CBM) meningitis in diabetic patients was analyzed for risk factors and outcome in a cohort of 201 cases of meningitis within last 17 years: 15 patients with diabetes mellitus and meningitis were identified and compared for etiology and mortality as well as for neurologic sequellae with all CBM cases.